z-logo
Premium
Dramatic response to encorafenib in a patient with E rdheim– C hester disease harboring the BRAF V600E mutation
Author(s) -
Wada Fumiya,
Hiramoto Nobuhiro,
Yamashita Daisuke,
Hara Shigeo,
Furukawa Yutaka,
Ishii Junko,
Nagata Kazuma,
Nannya Yasuhito,
Ogawa Seishi,
Ishikawa Takayuki
Publication year - 2021
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26232
Subject(s) - vemurafenib , dabrafenib , medicine , erdheim–chester disease , v600e , melanoma , mutation , oncology , cancer research , disease , histiocytosis , gene , biochemistry , chemistry , metastatic melanoma

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom